Hillard v. Pfizer, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Hillard v. Pfizer, Inc.

Sort by

Viewing results 1‒11 of 11

Covid-19 vaccines
Pfizer and Moderna forecast to almost double vaccine sales in 2022
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
October 18, 2021
Covid-19 vaccines
Africa will pay more for Russian Covid vaccine than ‘western’ jabs
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
February 25, 2021
FT Live
FTWeekend Festival: U.S. edition
Where the Financial Times weekend paper comes to life
Saturday, 4 MayThe REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
FT AlphavilleCoronavirus
The ESG case for the Oxford/AstraZeneca vaccine
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
December 23, 2020
Coronavirus treatment
EU fast-tracks process for Pfizer and BioNTech’s Covid-19 vaccine
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
October 6, 2020
LexMergers & Acquisitions
Letter from Lex: let’s make a deal
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
May 16, 2014
beyondbricsNeil Munshi
Ranbaxy’s high blood pressure day
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
November 30, 2011
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
US equities
Altria gains on court snub to anti-tobacco
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
June 28, 2010
FT AlphavilleEquities
CDS report: Spreads widen as investors await earnings season
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
July 6, 2009
News in-depthUK economy
Raised spirits
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
September 11, 2009
Mergers & Acquisitions
Signatories: ICC letter on the Doha Round to the editor of the Financial Times
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
February 28, 2007
Work & Careers
The big defence challenge
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
April 20, 2005

Previous pagePage 1 of 1Next page